Jaguar Health (JAGX) Gains from Investment Securities (2015 - 2018)
Jaguar Health's (JAGX) quarterly Gains from Investment Securities came in at $23000.0 in Q1 2018, down 94.93% year-on-year from $453419.0 in Q1 2017, and down 96.69% on a QoQ basis from $695341.0 in Q4 2017.
Jaguar Health (JAGX) Gains from Investment Securities (2015 - 2018) Analysis & Trends
Jaguar Health (JAGX) has 4 years of Gains from Investment Securities data on file, last reported at $23000.0 in Q1 2018.
- On a quarterly basis, Gains from Investment Securities fell 94.93% year-over-year to $23000.0 in Q1 2018; TTM through Mar 2018 was -$201321.0, a 132.13% decrease from a year earlier, with the FY2018 full-year figure at $23894.0, down 96.56% from the prior year.
- Gains from Investment Securities for Q1 2018 stood at $23000.0, down from $695341.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for JAGX reached as high as $695341.0 in Q4 2017 and fell as low as -$700740.0 in Q2 2017.
- Historically, Gains from Investment Securities has averaged $129854.6 across 4 years, with a median of $108150.5 in 2015.
- Across the five-year window, Gains from Investment Securities surged 1509.59% in 2017 and slumped 94.93% in 2018, its largest moves.
- Year by year, Gains from Investment Securities stood at $173101.0 in 2015, then plunged by 75.04% to $43200.0 in 2016, then soared by 1509.59% to $695341.0 in 2017, then plunged by 96.69% to $23000.0 in 2018.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $23000.0 in Q1 2018, $695341.0 in Q4 2017, and $23000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 23,000.00 |
| Mar 31, 2018 | 23,000.00 |
| Dec 31, 2017 | 695,341.00 |
| Dec 31, 2017 | 695,341.00 |
| Sep 30, 2017 | 23,000.00 |
| Sep 30, 2017 | 23,000.00 |
| Jun 30, 2017 | -700,740.00 |
| Jun 30, 2017 | -700,740.00 |
| Mar 31, 2017 | 453,419.00 |
| Mar 31, 2017 | 453,419.00 |
| Dec 31, 2016 | 43,200.00 |
| Dec 31, 2016 | 43,200.00 |
| Jun 30, 2015 | 173,101.00 |
| Jun 30, 2015 | 173,101.00 |
| Mar 31, 2015 | 328,516.00 |
| Mar 31, 2015 | 328,516.00 |